GlassScriptPhysician profile
Stuart G Knapp
NPI 1780979914
$1,604.35
in general payments reported to CMS, 2019-2025
17 companies · $279 in 2025
The $279 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48.99 · 2020: $109 · 2021: $262 · 2022: $266 · 2023: $303 · 2024: $336 · 2025: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $918.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $918.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $954.26 | 2021-2025 | |
| Novo Nordisk INC | $202.77 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $69.55 | 2020-2025 | Zepbound, Mounjaro |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $48.71 | 2019-2021 | |
| Amgen INC. | $47.90 | 2019-2022 | |
| Abbott Laboratories | $41.45 | 2021-2022 | |
| Allergan, INC. | $35.27 | 2020 | |
| Genentech USA, INC. | $28.33 | 2020-2022 | |
| Pfizer INC. | $27.34 | 2021-2023 | |
| Amarin Pharma, INC. | $25.16 | 2019 | |
| Xeris Pharmaceuticals, INC. | $23.87 | 2024 | Gvoke Hypopen |
| Takeda Pharmaceuticals U.S.A., INC. | $22.06 | 2023 | Trintellix |
| Exact Sciences Corporation | $21.38 | 2025 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $18.29 | 2023 | |
| Phathom Pharmaceuticals, INC. | $13.73 | 2024 | Voquezna |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $12.90 | 2020 | |
| Merck Sharp & Dohme LLC | $11.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Knapp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.